Clinical Trial: A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Solrikitug in Healthy Japanese and Non-Japanese Participants

U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06868082) titled 'A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Solrikitug in Healthy Japanese and Non-Japanese Participants' on Feb. 26.

Brief Summary: A Phase 1, Open-Label Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Two Formulations of Subcutaneously Administered Solrikitug in Healthy Japanese and non-Japanese Participants

Study Start Date: May 30

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: BIOLOGICAL: Solrikitug

Solrikitug Formulation 1

BIOLOGICAL: Solrikitug

Solrikitug Formulation 2

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Uniquity One (UNI)

Published by HT Dig...